the UK Archives - HealthQuill

A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely ineffective than a normal delivery, a study by the University of Cambridge found.

Birth by C-section may double the chance of measles vaccine failure

HQ Team May 17, 2024: A measles vaccine given to a child born by caesarean section is likely to be 2.6 times completely.

by HealthQuill
May 17, 2024
0 Comments

The smell of female mice may reduce the lifespan of a male mouse and accelerate its reproductive ageing, according to a study published in the Royal Society, a journal of the independent scientific academy of the UK.The smell of female mice may reduce the lifespan of a male mouse and accelerate its reproductive ageing, according to a study published in the Royal Society, a journal of the independent scientific academy of the UK.

Drugs Health Pharma

Female mice odour may cut short Romeo rodents’ life expectancy

HQ Team February 29, 2024: The smell of female mice may reduce the lifespan of a male mouse and accelerate its reproductive ageing,.

by HealthQuill
February 29, 2024
0 Comments

Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous treatments.

Drugs Health Pharma

Researchers find five cases of medically-acquired Alzheimer’s in UK

HQ Team February 12, 2024: Scientists have discovered five known cases of possible medically acquired Alzheimer’s disease after the patients have undergone previous.

by HealthQuill
February 12, 2024
0 Comments

African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned out to be ineffective in preventing people from getting the virus.

Drugs Health Pharma

African-European HIV vaccine clinical trials come to a grinding halt

HQ Team December 11, 2023: African researchers and European scientists, conducting clinical trials for an HIV vaccine, have halted further vaccinations after they turned.

by HealthQuill
December 11, 2023
0 Comments

Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market in Asia.

Drugs Health Pharma

Pfizer enters Hong Kong migraine market, its first in Asia

HQ Team September 29, 2023: Pfizer announced the availability of its migraine management drug Rimegepant in Hong Kong — the company’s first market.

by HealthQuill
September 29, 2023
0 Comments

The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.

Drugs Health Pharma

USFDA gives nod for GSK’s Ojjaara bone cancer therapy

The USFDA has approved GSK Plc’s oral therapy to treat anaemia in patients with myelofibrosis, a type of bone cancer.

by HealthQuill
September 17, 2023
0 Comments

A total of 34 confirmed cases of the COVID-19 virus variant, BA.2.86, have been identified in the UK, according to a government agency.

Drugs Health Pharma

Britain reports 34 cases of Covid-19 virus variant BA.2.86

HQ Team September 11, 2023: A total of 34 confirmed cases of the COVID-19 virus variant, BA.2.86, have been identified in the UK,.

by HealthQuill
September 11, 2023
0 Comments

Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a “controlled and limited” manner.

Drugs Health Pharma

Novo Nordisk’s weight-loss drug Wegovy enters the UK market

HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.

by HealthQuill
September 4, 2023
0 Comments

Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency.

Drugs Health Pharma

Roche’s under-the-skin cancer injection gets Britain’s nod

HQ Team August 30, 2023: Roche’s atezolizumab drug Tecentriq, to treat cancer, was approved by Britain’s Medicines and Healthcare Products Regulatory Agency. Tecentriq.